We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes.
- Authors
Nirenjen, S.; Narayanan, J.; Tamilanban, T.; Subramaniyan, Vetriselvan; Chitra, V.; Fuloria, Neeraj Kumar; Ling Shing Wong; Ramachawolran, Gobinath; Sekar, Mahendran; Gupta, Gaurav; Fuloria, Shivkanya; Chinni, Suresh V.; Selvaraj, Siddharthan
- Abstract
Background: Impaired wound healing is the most common and significant complication of Diabetes. While most other complications of Diabetes have better treatment options, diabetic wounds remain a burden as they can cause pain and suffering in patients. Wound closure and repair are orchestrated by a sequence of events aided by the release of pro-inflammatory cytokines, which are dysregulated in cases of Diabetes, making the wound environment unfavorable for healing and delaying the wound healing processes. This concise review provides an overview of the dysregulation of pro-inflammatory cytokines and offers insights into better therapeutic outcomes. Purpose of review: Although many therapeutic approaches have been lined up nowadays to treat Diabetes, there are no proper treatment modalities proposed yet in treating diabetic wounds due to the lack of understanding about the role of inflammatory mediators, especially Pro-inflammatory mediators- Cytokines, in the process of Wound healing which we mainly focus on this review. Recent findings: Although complications of Diabetes mellitus are most reported after years of diagnosis, the most severe critical complication is impaired Wound Healing among Diabetes patients. Even though Trauma, Peripheral Artery Disease, and Peripheral Neuropathy are the leading triggering factors for the development of ulcerations, the most significant issue contributing to the development of complicated cutaneous wounds is wound healing impairment. It may even end up with amputation. Newer therapeutic approaches such as incorporating the additives in the present dressing materials, which include antimicrobial molecules and immunomodulatory cytokines is of better therapeutic value. Summary: The adoption of these technologies and the establishment of novel therapeutic interventions is difficult since there is a gap in terms of a complete understanding of the pathophysiological mechanisms at the cellular and molecular level and the lack of data in terms of the assessment of safety and bioavailability differences in the individuals’ patients. The target-specific proinflammatory cytokines-based therapies, either by upregulation or downregulation of them, will be helpful in the wound healing process and thereby enhances the Quality of life in patients, which is the goal of drug therapy.
- Subjects
WOUND healing; DIABETES complications; PERIPHERAL vascular diseases; CYTOKINES; THERAPEUTICS
- Publication
Frontiers in Immunology, 2023, p1
- ISSN
1664-3224
- Publication type
Academic Journal
- DOI
10.3389/fimmu.2023.1216321